glp-1 trump Donald LIVE: Trump Announces Deal To Lower Cost Of Weight Loss Drugs President Trump announced the popular

The effect of GLP1 receptor agonists on mood and cognition: a systematic review and metaanalysis of randomized controlled trials

The glucagon-like peptide-1 receptor--or not

Semaglutide GLP-1 is an FDA-approved option for weight loss that works by regulating appetite and supporting healthy metabolic function

Without meticulous data, you cannot determine whether each switch is producing benefit or just causing disruption

So at least in that regard, if patients are obtaining drug from a pharmacy that has a reputation for quality products, I feel a little more comfortable, but as you mentioned, the regulation is not as robust, if you will.